A Focus On Next-Generation Brain Surgery Could Make This Stock A No-Brainer
The company featured in today’s article is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain – and…
The company featured in today’s article is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain – and…
“Scared money runs and misses out on profits, while smart money is always poised to pounce on temporary disconnects,” declares the author of today’s article…
“As corporate budgets start to thaw this year along with a gradually reopening economy, AI applications are expected to receive plenty of attention,” notes the…
Amid the ongoing opioid crisis, the need for non-opioid pain management solutions is increasing. As a provider of pre- and post-surgical non-opioid pain management solutions,…
With a portfolio currently comprised of 45 commercial products and five developmental-stage candidates in various areas, including rare disease and neurology, the company featured in…
On the heels of the news of Roche acquiring GenMark Diagnostics, the author of today’s article shares two more leading diagnostics companies that he believes are prime…
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…
“With a huge tailwind from the massive stimulus program and the reopening of the economy as spring begins, now is the time to move from…
“With the number of new equity traders skyrocketing over the past year due to the Reddit/WallStreetBets popularity, locating good ideas to trade has become even…
“After lagging the broad market rebound in 2020, smaller companies staged a comeback in the latter part of that year and have been on a…